| NCT Number | NCT07147023 |
| Lead Sponsor | Dana-Farber Cancer Institute |
| Conditions | Advanced Cancer, Cancer, End of Life |
| Enrollment | 60 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-04-15 (estimated) |
| Study Completion | 2026-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-28 |